Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-75, Consolidated Appropriations Act, 2026, Division A - Department of Defense Appropriations Act, 2026; and Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Department of Defense Appropriations Act, 2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · 1st Quarter (Jan 1 - Mar 31)
NEUROFIBROMATOSIS, INC. MIDWEST
Filed by VAN SCOYOC ASSOCIATES.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 17, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- VAN SCOYOC ASSOCIATES
- Filing UUID
- 46e354ed-20c9-4852-858d-b68eb3eac221
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-75, Consolidated Appropriations Act, 2026, Division A - Department of Defense Appropriations Act, 2026 Department of Defense Appropriations Act, 2027
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.